Intralymphatic immunotherapy with a grass allergen microcrystalline tyrosine adsorbate resulted in reduced medication use and symptoms in patients with allergic rhinoconjunctivitis: a double-blind randomized placebo-controlled trial

Intralymphatic immunotherapy with a grass allergen microcrystalline tyrosine adsorbate resulted in reduced medication use and symptoms in patients with allergic rhinoconjunctivitis: a double-blind randomized placebo-controlled trial

Lara Šošić, Bjarke Hviid-Vyff, Stephan Flory, Johannes M. Schmid, Claudia Lang, Peter Schmid-Grendelmeier, Lars Ahlbeck, Maibritt Mardahl, Matthias F. Kramer, Matthew D. Heath, Simon J. Hewings, Murray A. Skinner, Thomas M. Kündig, Hans Jürgen Hoffmann, Pål Johansen; Session OAS 6 - Frontiers in Allergen Immunotherapy: evidence from clinical trials; EAACI 2024 Congress.